A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Arformoterol
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Rilpivirine.
Arformoterol
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Rilpivirine.
Arformoterol
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Rilpivirine.
Arformoterol
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Rilpivirine.
Arformoterol
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Rilpivirine.
Arformoterol
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Rilpivirine.
Arformoterol
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Rilpivirine.
Arformoterol
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Rilpivirine.
Arformoterol
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Rilpivirine.
Arformoterol
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Rilpivirine.
Arformoterol
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Rilpivirine.
Arformoterol
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Rilpivirine.
Arformoterol
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Rilpivirine.
Arformoterol
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Rilpivirine.
Arformoterol
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Rilpivirine.
Arformoterol
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Rilpivirine.
Arformoterol
Pralsetinib
Rilpivirine may decrease the excretion rate of Pralsetinib which could result in a higher serum level.
Arformoterol
Fostemsavir
Rilpivirine may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Arformoterol
Ripretinib
Rilpivirine may decrease the excretion rate of Ripretinib which could result in a higher serum level.
Arformoterol
Glecaprevir
Rilpivirine may decrease the excretion rate of Glecaprevir which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3